< Back

November/ December 2006 Vol.8 No.6
Cost to develop new biotech products is estimated to average $1.2 billion
View summary    Purchase single issue

September/October 2006, Vol. 8, No.5
Fastest Drug Developers Consistently Outperform Their Peers, Generating Substantially Higher Revenue and Cost Savings
View summary    Purchase single issue

July/August 2006, Vol. 8, No. 4
Little growth seen in vaccine R&D for rest of decade
View summary    Purchase single issue

May/June 2006, Vol. 8, No. 3
New drugs entering clinical testing in top 10 firms jumped 52% in 2003-05
View summary    Purchase single issue

March/April 2006, Vol. 8, No. 2
Fast track program firmly established in U.S. drug development landscape
View summary    Purchase single issue

January/February 2006, Vol. 8, No. 1
CRO contribution to drug development is substantial and growing globally
View summary    Purchase single issue